SPP1 and cystic kidney disease: Limitations of this work include use of a single model of cystic kidney disease, global (non‐targeted) deletion of the Spp1 gene, no investigation of phenotypic changes in kidney macrophage subpopulations, and lack of a definitive explanation as to how OPN deletion could reduce cyst burden while exacerbating kidney fibrosis in this model.